Joe Yamada,1,
Hitoshi Uga,2
Yuki Yamaguchi,1
Tadashi Wada,1 and
Hiroshi Handa1,2*
Frontier Collaborative Research Center,2 Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Midori-ku, Yokohama, Japan1
Received 6 May 2004/ Returned for modification 21 June 2004/ Accepted 29 September 2004
| ABSTRACT |
|---|
|
|
|---|
B ligand is essential for inducing the differentiation of mature osteoclasts. We find that nuclear factor Y (NF-Y) binds to the CCAAT box on the ODF promoter and regulates its basal transcriptional activity. The CCAAT box on the ODF gene is required for its transcriptional induction by vitamin D3, suggesting that NF-Y coregulates this promoter along with VDR. Chromatin immunoprecipitation analysis reveals that NF-Y is required for the recruitment of RNA polymerase II (RNAPII) and TATA box binding protein on the ODF promoter. Stimulation with vitamin D3 facilitates the recruitment of VDR and p300 onto the ODF promoter, resulting in acetylation of histone H4 in an NF-Y-independent manner. ODF gene induction by parathyroid hormone or prostaglandin E is also dependent on NF-Y. Furthermore, NF-Y is essential for the recruitment of RNAPII onto other CCAAT box-containing promoters, such as those of osteopontin, CYP24, and E2F1. These results suggest that NF-Y recruits RNAPII and general transcription factors onto various CCAAT box-containing promoters in response to various inductions to permit strong transcriptional activation independently of histone modifications. | INTRODUCTION |
|---|
|
|
|---|
Osteoclast differentiation factor (ODF) is an essential factor for differentiation and activation of osteoclasts that is expressed on the osteoblast membrane (22, 43). ODF is also known as TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine) and RANKL (receptor activator of NF-
B ligand) (3, 39). ODF knockout mice exhibit typical osteoporosis with total occlusion of bone marrow space within endosteal bone (21) and also fail to develop mammary glands (10). In ODF/ mice, mature osteoclasts are not found, whereas osteoclast progenitor cells are present. These observations indicate that ODF is an essential factor for developing mature osteoclasts and inducing bone resorption.
ODF gene expression is induced by vitamin D3, parathyroid hormone (PTH), interleukin-1 (IL-1), TNF-
, and PGE in primary osteoblasts or stromal cells (12, 27, 35, 43). The mouse ODF promoter region contains a vitamin D3 response element (VDRE) (19, 20). A heterodimer of vitamin D3 receptor (VDR) and retinoid X receptor (RXR) mediates vitamin D3 response (30). VDR-RXR transactivates target genes by recruiting transcriptional coactivators and mediators, such as the DRIP complex, which mediates transcriptional initiation, and the SRC-1/p300 complexes, which induce histone acetylation on target genes (13, 31, 32). The mouse ODF promoter also contains a CCAAT sequence near the transcriptional start site, but its significance is not known.
In this report, we show that NF-Y is essential for transcriptional regulation of the ODF promoter. NF-Y exhibits a synergistic effect with vitamin D3 in activating this promoter. Knockdown analysis for an NF-Y subunit reveals that NF-Y is essential for the recruitment of RNAPII prior to induction but not for histone acetylation after vitamin D3 induction on the ODF promoter. Furthermore, NF-Y is also required for RNAPII recruitment onto other CCAAT box-containing promoters, such as those of osteopontin (OPN), CYP24, and E2F1.
| MATERIALS AND METHODS |
|---|
|
|
|---|
The mouse OPN gene was a kind gift of T. Yamamoto (Ohita Medical University). pOPN, which includes the region 2977 to +13, was constructed as follows. Fragments of the OPN gene were amplified by PCR and modified by enzymatic reactions to create a protruding NheI site and an end-filled EcoRI site. These fragments were ligated into the NheI site and the end-filled HindIII site of pGV-B. pOPN72 and pOPN72CCCAATmt were constructed as follows. OPN gene fragments 72 to +13, with or without mutation in the CCAAT box, were generated by PCR, digested with EcoRI and HindIII, and end filled. These fragments were ligated into the end-filled HindIII site of pOPN.
Cell culture and reporter gene assay.
ST-2 cells were maintained in MEM
(Gibco BRL) supplemented with 10% fetal bovine serum. For the reporter gene assays, 0.2 µg of luciferase expression vector containing various promoters and 0.2 µg of pSV-ß-galactosidase (Promega) were cotransfected into ST-2 cells (5 x 104 cells/35-mm-diameter dish) using Effectene reagent (QIAGEN). The cells were incubated for 12 h before the transfection mixture was replaced with fresh medium, followed by treatment with or without 30 nM calcitriol (ROUSSEL UCLAF). After 36 h, the cells were harvested and luciferase and ß-galactosidase activities were analyzed.
Electrophoretic mobility shift assay (EMSA).
Nuclear extracts (NE) were prepared from ST-2 cells using the Dignam method (7). The following oligonucleotides were used as probes: mouse ODF promoter, region 80 to 50, sense strand (5'-gggACCCTCCTGGAAGCTGATTGGCTCTGGAGG-3') and antisense strand (5'-gggCCTCCAGAGCCAATCAGCTTCCAGGAGGGT-3') for the CCAAT box; and region +33 to approximately +47, sense strand (5'-gggGGACCTCTGTGAACC-3') and antisense strand (5'-gggGGTTCACAGAGGTCC-3') for VDRE. The annealed oligonucleotides were labeled with Klenow fragments in the presence of [
-32P]dCTP. The labeled probes were incubated with ST-2 nuclear extracts in a reaction mixture containing 20 mM HEPES (pH 7.9), 100 mM KCl, 12% glycerol, 0.5 mM EDTA, 0.6 mM dithiothreitol, and 50 ng of poly(dI-dC)/µl at 30°C for 30 min. A mixture of recombinant VDR and RXR
was generated with an in vitro translation system (Promega), and 2 µl of the product was used for the assay. The samples were loaded on 5% acrylamide gels and electrophoresed at 200 V for 2 h and were autoradiographed.
Reverse transcription-PCR (RT-PCR). ST-2 cells (106 cells/100-mm-diameter dish) were grown for 24 h and treated with 100 nM calcitriol for various time periods from 0 to 48 h. After incubation, the cells were washed twice with phosphate-buffered saline() [PBS()], and total RNA was extracted with Sepasol-RNA I (Nacalai tesque). The first-strand cDNA was synthesized from total RNA by SuperScript II (Life Technologies). PCRs were performed with KOD DNA polymerase (TOYOBO) using GeneAmp 9600 and the following primers: ODF sense, 5'-CGCAGATGGATCCTAACAGAATATCA-3'; ODF antisense, 5'-CTTGGGATTTTGATGCTGGTTTTAAC-3'; OPN sense, 5'-AGTTTCCAGGTTTCTGATGAACAG-3'; OPN antisense, 5'-TTAGTTGACCTCAGAAGATGAACT-3'; GAPDH sense, 5'-ACTTTGTCAAGCTCATTTCC-3'; GAPDH antisense, 5'-TGCAGCGAACTTTATTGATG-3'; epidermal growth factor receptor (EGFR) sense, 5'-CACTACATTGATGGCCCACACTGTG-3'; EGFR antisense, 5'-TTAGATCCAAAAGGTCTTTAAGATC-3'; CYP24 sense, 5'-CCAAGTGCTGGGCTCTAGCGAAG-3'; CYP24 antisense, 5'-CTACCGTGGACAGAACGCAATGGG-3'; E2F1 sense, 5'-ATCGGAGCCTCCGTCGTCACA-3'; E2F1 antisense, 5'-AGGCCGCGGCGAGGGCTCGAT-3'; OPN sense, 5'-AGTTTCCAGGTTTCTGATGAACAG-3'; OPN antisense, 5'-TTAGTTGACCTCAGAAGATGAACT-3'. A thermal cycle of 98°C, 15 s; 68°C (ODF), 63°C (OPN), or 60°C, 10 s; and 74°C, 30 s was repeated for 35 cycles for ODF, 30 cycles for OPN, CYP24, p21, EGFR, and E2F1, or 25 cycles for GAPDH. PCR products were electrophoresed on 1.5% agarose gels and were stained with ethidium bromide (EtBr).
Chromatin immunoprecipitation assay (ChIP). ST-2 cells (3 x 105 cells/100-mm-diameter dish) were incubated for 3 days with or without vitamin D3 and for an additional 24 h with 5 mM sodium butyrate, a histone deacetylase inhibitor. Formaldehyde was added to the culture medium at a final concentration of 1% for 10 min at 25°C, and then fixation was stopped by the addition of 0.125 M glycine. The fixed cells were washed twice with PBS() and harvested. Cells were suspended in a buffer containing 20 mM HEPES (pH 7.9), 85 mM KCl, 0.5% NP-40, and 0.5 mM phenylmethylsulfonyl fluoride (PMSF), incubated for 20 min on ice, and then vortexed. Nuclei were collected by centrifugation at 5,000 rpm (TOMMY XL-160) at 4°C for 5 min, suspended in a solution of 1% sodium dodecyl sulfate (SDS), 50 mM Tris (pH 8.0), and 0.5 mM PMSF, and incubated for 10 min on ice. The samples were sonicated for 10 min to cleave genomic DNA to an average length of 1,000 bp and were centrifuged at 15,000 rpm at 4°C for 10 min. Following a fivefold dilution of the nuclear lysates using NP-40 lysis buffer (20 mM Tris, 100 mM NaCl, 1 mM EDTA, and 0.1% NP-40), samples were incubated overnight at 4°C with 5 µg of antibody/ml against NF-YB (Santa Cruz), VDR (ARB Co.), RNA polymerase II (8WG16 or H5), TBP (3G3; a kind gift from L. Tora), p300 (Santa Cruz), or acetylated histone H4 (Upstate Biotechnology). A 60-µl aliquot of protein A- or G-conjugated Sepharose beads (Upstate Biotechnology) containing 1 µg of salmon sperm DNA fragments/µl and 1 µg of bovine serum albumin/µl was added and incubated at 4°C for 1 h. Sepharose beads were washed four times with NP-40 lysis buffer. The beads were incubated with 0.3 M NaCl for 6 h at 65°C. The eluates were incubated with proteinase K for 1 h at 45°C and extracted with phenol-CHCl3, and DNA was recovered by ethanol precipitation. PCR was performed using the following primers: ODF forward primer, 5'-TTTGCTAGCGGGCAGATGTGGGAGTGA-3'; ODF reverse primer, 5'-AAGCTTCCCGCCCCGACCGTTCACA-3'; OPN forward primer, 5'-TTTGAATTCAAACCAGAGGAGGAGTGTA-3'; OPN reverse primer, 5'-AAAAGGCTTTTGGTGGTGGGGTCAGACCTCCCAGA-3'; ODF 2000 forward primer, 5'-ACTTTGTCAAGCTCATTTCC-3'; ODF 1500 reverse primer, 5'-TGCAGCGAACTTTATTGATG-3'; CYP24 forward primer, 5'-AGATGAAAATACAAGGGCTGGC-3'; CYP24 reverse primer, 5'-TATTCACCTGTATCGTCAGATC-3'; p21 forward primer, 5'-AACCCAGGGCTTCACTTCCAGCAAG-3'; p21 reverse primer, 5'-TGAACCAACTGTGGGAAGGACTAACTCT-3'; EGFR forward primer, 5'-AGCCCCAGCGCAACGCGCAGCAGCC-3'; EGFR reverse primer, 5'-CGCGTCCAGGTGACCTGTCGTCTGTC-3'; E2F forward primer, 5'-ATCGGAGCCTCCGTCGTCACA-3'; E2F reverse primer, 5'-AGGCCGCGGCGAGGGCTCGAT-3'. A thermal cycle of 98°C, 15 s; 60°C, 10 s; and 74°C, 30 s was repeated for 30 cycles. PCR products were separated on 1.5% agarose gels and were stained with EtBr or quantified with a GeneAmp 5700 (Applied Biotechnologies).
Silencer RNA for NF-YA mRNA. A silencer RNA (siRNA) for NF-YA was designed in the region 142 to 164 of the mouse NF-YA mRNA as follows: sense strand, 5'-GUCCAGACCCUCCAGGUAGUU-3'; antisense strand, 5'-CUACCUGGAGGGUCUGGACUU-3'. cRNA strands were transcribed in vitro using the Silencer small interfering RNA (siRNA) construction kit (Ambion), and double-stranded RNA (dsRNA) was generated. siRNA products were transfected into ST-2 cells (104 cells/24-well dish) using DMRIE-C reagents (Invitrogen). Six hours later, the transfection mixtures were replaced with fresh medium and cells were treated with or without 30 nM vitamin D3 for 48 h. Cells were washed with PBS() twice and were lysed with lysis buffer (50 mM Tris [pH 7.6], 400 mM NaCl, and 1% Nonidet P-40). Cell lysates (10 µg) were separated on a SDS-12.5% polyacrylamide gel and transferred to polyvinylidene difluoride membrane (Millipore). Proteins of interest were visualized using anti-NF-YA (Santa Cruz) or RNAPII (8WG16) antibody and ECL (Amersham). RT-PCR analysis and ChIP assays were performed as described above.
| RESULTS |
|---|
|
|
|---|
|
NF-Y is required for transcription of the ODF gene and recruitment of RNAPII to the promoter. To examine the interaction between NF-Y and the CCAAT box of the ODF gene in vivo, we employed a chromatin immunoprecipitation assay (Fig. 2A). Western blot analysis revealed that similar amounts of endogenous NF-YB subunit were specifically immunoprecipitated from the formaldehyde cross-linked ST-2 cell extracts with anti-NF-YB antibody, irrespective of vitamin D3 stimulation (Fig. 2A, upper panel). Under these conditions, immunoprecipitated DNA fragments were analyzed by PCR. Amplified DNA fragments were detected in anti-NF-YB-immunoprecipitated samples irrespective of vitamin D3 stimulation when primers designed for the ODF (105 to +55) promoter were used but not when primers designed for the distal region (2000 to 1500) were used (Fig. 2A, lanes 7 and 8). These results suggest that NF-Y specifically recognizes the CCAAT box under both induced and uninduced conditions in ST-2 cells.
|
In ST-2 cells, the level of ODF mRNA was clearly increased by vitamin D3 treatment (Fig. 2B, lanes 9, 11, 13, and 15). Under induced and uninduced conditions, NF-YA siRNA treatment led to a significant decrease in the expression level of ODF with little effect on GAPDH expression (Fig. 2B, lanes 10, 12, 14, and 16). This indicates that NF-Y is essential for ODF gene expression in ST-2 cells.
We next examined the molecular function of NF-Y on the ODF promoter (lanes 17 to 24). NF-YB constitutively bound to the ODF promoter throughout the 24-h period of vitamin D3 treatment, and this binding was decreased by siRNA for NF-YA. These results are consistent with the idea that formation of the ternary complex of NF-YA, NF-YB, and NF-YC is necessary for DNA binding. VDR bound to the ODF promoter region after vitamin D3 stimulation. The coactivator p300 was also recruited to the ODF promoter after treatment with vitamin D3. Similarly, histone H4 on the ODF promoter was acetylated after vitamin D3 treatment. VDR binding, p300 recruitment, and histone H4 acetylation were not affected by treatment with siRNA for NF-YA. On the contrary, RNAPII and TBP constitutively bound to the ODF promoter, and knockdown of NF-YA inhibited the recruitment of these factors regardless of vitamin D3 stimulation. Quantitative PCR analysis (Fig. 2C) showed that NF-YA siRNA reduced binding of NF-YB and RNAPII to the ODF promoter by 60% but had no effect on acetylation of histone H4. Interestingly, association of the IIo form of RNAPII (H5) with the ODF promoter was increased 1.5- to 2-fold by vitamin D3 treatment, and NF-YA knockdown suppressed this enhancement. These results indicate that NF-Y presets RNAPII and general transcription factors (GTF) (TBP) on the ODF promoter and that vitamin D3 induces transcriptional activation through phosphorylation of the RNAPII C-terminal domain (CTD) and acetylation of histones on the ODF promoter.
The CCAAT box is required for transcriptional induction by vitamin D3 on the ODF and OPN genes.
Because the importance of NF-Y in both basal and inducible transcription of the endogenous ODF gene was established, we next examined cis-acting elements on the ODF gene in greater detail (Fig. 3). Previously, Kitazawa et al. reported that a putative VDRE is located at 928 bp on the mouse ODF promoter (19). As shown above, VDR is assembled onto the ODF core promoter region (Fig. 2B). Using EMSA, we identified another VDRE sequence at the region +33 to +47 (GGTTCAcagAGGTCC) in the 5' untranslated region (5'UTR) (Fig. 3A). When this region was used as a DNA probe, a shifted band was detected by incubation with in vitro-translated VDR and RXR
(Fig. 3A, lane 2). A shifted band was also detected at a similar position by incubation with vitamin D3-treated ST-2 NE (lane 4) but not with untreated NE (lane 3). Anti-VDR antibody inhibited formation of the protein-DNA complex (lane 6). These results suggest that the VDR-RXR complex binds to the region +33 to +47 of the mouse ODF gene.
|
31 containing 961 to +31, but not including the 5'UTR VDRE, exhibited no transcriptional induction by vitamin D3. These results suggest that the 5'UTR VDRE is required for vitamin D3 induction. Because we observed only a low level of induction by vitamin D3 on these constructs, we next prepared the reporter plasmid pVDRE-ODF80, which is pODF80 with an extra VDRE derived from the human osteocalcin gene. Using this construct, 4.2-fold transcriptional induction was observed. Next we examined the role of the CCAAT box on the ODF promoter in vitamin D3 induction using the reporter plasmids shown in Fig. 3C. While pVDRE-ODF80 showed more than threefold transcriptional induction by vitamin D3, pVDRE-ODF80CCAATmt and ODF55, whose CCAAT box was either mutated or deleted, showed little induction. These results indicate that not only the VDREs but also the CCAAT box are required for transcriptional induction of the ODF gene by vitamin D3. Osteopontin (OPN) is also expressed from osteoblasts following vitamin D3 stimulation. As shown in Fig. 3D, the mouse OPN promoter region includes two VDRE sites and a CCAAT box. Previously, Kim and Sodek reported that the NF-Y complex binds to the CCAAT box of the OPN gene in nuclear extracts of mouse fibroblast NIH 3T3 cells (18). We also found that NF-Y binds to the CCAAT box with ST-2 NE on EMSA (data not shown). We examined the role of the CCAAT box in vitamin D3 induction of the OPN gene. When the reporter plasmid pOPN, containing 2977 to +13 of the OPN promoter, was used, eightfold transcriptional induction by vitamin D3 was observed. When pOPN72, lacking the cbfa1 site, was used, a 75% decrease in basal transcriptional activity was observed, whereas induction by vitamin D3 was unaffected. In contrast, induction by vitamin D3 was abolished by mutation of the CCAAT box. These results indicate that the CCAAT box is necessary for vitamin D3-induced expression of the OPN gene.
NF-Y is essential for ODF gene expression following PTH or PGE stimulation. ODF gene expression is also induced by PTH or PGE stimulation (42). We further analyzed transcriptional regulation on the ODF promoter with these stimulations (Fig. 4). PTH or PGE stimulation is known to induce activation of the CREB family of transcription factors through protein kinase A phosphorylation in osteoblasts, but the mechanism of transcriptional regulation of ODF is not clear. The level of the ODF mRNA increased 12 or 24 h after treatment of ST-2 cells with either PTH or PGE (lanes 5, 7, 13, and 15). The NF-YA siRNA treatment significantly reduced these inductions (lanes 6, 8, 14, and 16). These results indicate that NF-Y is essential for ODF expression following PTH or PGE stimulation. Under these conditions, ChIP assay was performed. NF-YB and RNAPII were assembled onto the ODF promoter independent of PTH or PGE stimulation, and p300 recruitment and acetylation of histone H4 was gradually induced in response to these stimulations. Knockdown of NF-YA inhibited the assembly of NF-YB and RNAPII on the ODF promoter but did not affect p300 recruitment and acetylation of histone H4. These results underscore the importance of NF-Y on both basal and inducible transcription of the ODF gene.
|
|
| DISCUSSION |
|---|
|
|
|---|
NF-Y is a ubiquitous transcription factor that activates the basal transcriptional activity of various promoters through CCAAT boxes. Over 25% of eukaryotic promoters contain CCAAT boxes, in most cases within 100 bp of transcription start sites (26). We showed that NF-Y constitutively binds to all the CCAAT box-containing promoters examined. RNAPII and TBP also constitutively bind to these promoters in an NF-Y-dependent manner. Because NF-Y has been shown to associate with TBP and several TAFs (5, 11), NF-Y may recruit preinitiation complexes through binding to TFIID. NF-Y is also necessary for recruiting RNAPII to the TATA-less E2F1 gene. This indicates that a CCAAT box, when recognized by NF-Y, efficiently facilitates preinitiation complex formation in the absence of a TATA box. DNA binding subunits NF-YB and NF-YC have a histone folding motif and, together with NF-YA, tightly bind to a CCAAT sequence (17). NF-Y may create a core promoter architecture that is suitable for assembly of a preinitiation complex. In a recent study, Duan et al. (9) have shown that a CCAAT box is required for the formation of the transcription initiation complex containing RNAPII, TBP, and TFIIB. The authors did so by introducing DNA fragments of the
-globin gene promoter, containing a wild-type or mutated CCAAT box, into mouse MEL cells exogenously (9). On the other hand, we clearly showed that NF-Y is necessary for recruitment of RNAPII in vivo by using siRNA for NF-YA.
In this study, we found that the CCAAT boxes of the ODF and OPN genes are required for transcriptional induction by vitamin D3. Furthermore, knockdown of NF-YA expression significantly decreased vitamin D3-induced ODF and OPN gene expression. However, physical interaction between VDR and NF-Y could not be detected in vivo or in vitro (data not shown). It has been reported that NF-Y cooperates with several transcription factors, such as SP-1, ATF-2, RFX, and SREBP1, and that it synergistically enhances transcriptional activity of several promoters (2, 16, 36, 40). However, there are few reports on physical interactions of these transactivators with NF-Y. NF-Y may therefore exhibit a synergistic effect through interacting with some coactivators. Contrary to this view, however, knockdown of NF-YA did not affect recruitment of p300. These points suggest that VDR and NF-Y may act independently of each other through binding to their respective cis elements.
It is known that transcription factors of the nuclear receptor family, including VDR, transactivate through recruiting several coactivators (SRC-1/p300) or mediators (DRIP/TRAP complex) in a ligand-dependent manner (30). The estrogen receptor recruits the preinitiation complex through recruiting coactivators upon estrogen induction (34). It was also reported that the mediator DRIP complex interacts with several TAFs and mediates the preinitiation complex upon induction (4, 41). We consistently observed that the recruitment of RNAPII is dependent on vitamin D3 induction on the EGFR and p21 promoters, which do not contain the CCAAT box. However, RNAPII and TBP (GTFs) are preset by NF-Y on the CCAAT box-containing promoters of the ODF, OPN, and CYP24 genes. Interestingly, phosphorylation of the CTD of RNAPII that is preset on the ODF promoter is induced by vitamin D3 (Fig. 4B and C). Phosphorylation of the RNAPII CTD is thought to enhance the rate of elongation reaction (41). Thus, mediators and coactivators might transactivate a subset of vitamin D3-inducible genes in part through phosphorylation of the RNAPII CTD.
Recruitment of VDR and p300 to the ODF gene was only observed following vitamin D3 induction. This effect was time-dependent and synchronized with increased acetylation of histone H4. NF-YA knockdown showed no effect on the progression of acetylation of histone H4. This suggests that the acetylation of histone H4 is independent of NF-Y. NF-Y is known to associate with p300/PCAF and GCN5, coactivators with histone acetyltransferase activity. It has been reported on the basis of results of DNase I protection assays and ChIP analysis that NF-Y potentiates histone acetylation on the Xenopus hsp70 promoter (23, 24) and the cyclin B2 promoter (33). These promoters have two or three CCAAT boxes, and NF-Y binds to each CCAAT box independently. It is thought that binding of multiple NF-Ys recruits p300 (33). On promoters containing a CCAAT box, such as the ODF promoter, histone modification might be directed by transactivators, like VDR, other than NF-Y.
According to a recent report, SP1 plays a role in presetting RNAPII. Before TNF-
stimulation, RNAPII is preset on the A20 core promoter region, which is dependent on the GC box of the A20 gene (1). The OPN, E2F1, and p21 genes also have GC boxes that are recognized by SP1 (29, 36, 37). Because RNAPII recruitment was significantly decreased by NF-Y knockdown on the OPN and E2F1 genes, RNAPII recruitment is dependent on NF-Y on these promoters. Furthermore, RNAPII recruitment on the p21 gene was at a very low level prior to induction, and stimulation with vitamin D3 significantly induced the RNAPII recruitment. Thus, the role for SP1 in presetting RNAPII is very small, if any, on these promoters.
On the basis of our results, we present a model of transcriptional regulation of vitamin D3-inducible genes, which is illustrated schematically in Fig. 6. On vitamin D3-inducible genes containing a CCAAT box, such as ODF, OPN, and CYP24, NF-Y constitutively binds to the CCAAT box and presets the basal transcriptional state by recruiting RNAPII and GTFs to the promoter. Following vitamin D3 stimulation, VDR-RXR and p300 are assembled onto the promoter, increase histone acetylation, and activate transcription at a postpreinitiation complex assembly step. Thus, recruitment of RNAPII by NF-Y permits rapid transcriptional induction and synthesis of a greater amount of transcripts. On the other hand, on vitamin D3-inducible genes lacking a CCAAT box, such as EGFR and p21, promoters are not occupied by RNAPII and GTFs prior to induction. Following vitamin D3 stimulation, VDR-RXR, p300, and probably the mediator complex are assembled onto the promoter and activate transcription at a preinitiation complex assembly step and the subsequent steps.
|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Y.K. and J.Y. contributed equally to this work. ![]()
| REFERENCES |
|---|
|
|
|---|
B. Mol. Cell. Biol. 22:6354-6362.
2. Alonso, C. R., C. G. Pesce, and A. R. Kornblihtt. 1996. The CCAAT-binding proteins CP1 and NF-I cooperate with ATF-2 in the transcription of the fibronectin gene. J. Biol. Chem. 271:22271-22279.
3. Anderson, D. M., E. Maraskovsky, W. L. Billingsley, W. C. Dougall, M. E. Tometsko, E. R. Roux, M. C. Teepe, R. F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179.[CrossRef][Medline]
4. Baek, H. J., S. Malik, J. Qin, and R. G. Roeder. 2002. Requirement of TRAP/mediator for both activator-independent and activator-dependent transcription in conjunction with TFIID-associated TAF(II)s. Mol. Cell. Biol. 22:2842-2852.
5. Bellorini, M., D. K. Lee, J. C. Dantonel, K. Zemzoumi, R. G. Roeder, L. Tora, and R. Mantovani. 1997. CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues. Nucleic Acids Res. 25:2174-2181.
6. Currie, R. A. 1998. NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF. J. Biol. Chem. 273:1430-1434.
7. Dignam, J. D. 1990. Preparation of extracts from higher eukaryotes. Methods Enzymol. 182:194-203.[Medline]
8. Dorn, A., J. Bollekens, A. Staub, C. Benoist, and D. Mathis. 1987. A multiplicity of CCAAT box-binding proteins. Cell 50:863-872.[CrossRef][Medline]
9. Duan, Z., G. Stamatoyannopoulos, and Q. Li. 2001. Role of NF-Y in in vivo regulation of the gamma-globin gene. Mol. Cell. Biol. 21:3083-3095.
10. Fata, J. E., Y. Y. Kong, J. Li, T. Sasaki, J. Irie-Sasaki, R. A. Moorehead, R. Elliott, S. Scully, E. B. Voura, D. L. Lacey, W. J. Boyle, R. Khokha, and J. M. Penninger. 2000. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103:41-50.[CrossRef][Medline]
11. Frontini, M., C. Imbriano, A. diSilvio, B. Bell, A. Bogni, C. Romier, D. Moras, L. Tora, I. Davidson, and R. Mantovani. 2002. NF-Y recruitment of TFIID, multiple interactions with histone fold TAF(II)s. J. Biol. Chem. 277:5841-5848.
12. Hofbauer, L. C., D. L. Lacey, C. R. Dunstan, T. C. Spelsberg, B. L. Riggs, and S. Khosla. 1999. Interleukin-1ß and tumor necrosis factor-
, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25:255-259.[Medline]
13. Hong, H., K. Kohli, M. J. Garabedian, and M. R. Stallcup. 1997. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell. Biol. 17:2735-2744.[Abstract]
14. Hsiao, K. M., S. L. McMahon, and P. J. Farnham. 1994. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev. 8:1526-1537.
15. Jin, S., and K. W. Scotto. 1998. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol. 18:4377-4384.
16. Jump, D. B., A. P. Thelen, and M. K. Mater. 2001. Functional interaction between sterol regulatory element-binding protein-1c, nuclear factor Y, and 3,5,3'-triiodothyronine nuclear receptors. J. Biol. Chem. 276:34419-34427.
17. Kim, I. S., S. Sinha, B. de Crombrugghe, and S. N. Maity. 1996. Determination of functional domains in the C subunit of the CCAAT-binding factor (CBF) necessary for formation of a CBF-DNA complex. Mol. Cell. Biol. 16:4003-4013.[Abstract]
18. Kim, R. H., and J. Sodek. 1999. Transcription of the bone sialoprotein gene is stimulated by v-Src acting through an inverted CCAAT box. Cancer Res. 59:565-571.
19. Kitazawa, R., S. Kitazawa, and S. Maeda. 1999. Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. Biochim. Biophys. Acta 1445:134-141.[Medline]
20. Kitazawa, R., and S. Kitazawa. 2002. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter. Biochem. Biophys. Res. Commun. 290:650-655.[CrossRef][Medline]
21. Kong, Y. Y., H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, W. Khoo, A. Wakeham, C. R. Dunstan, D. L. Lacey, T. W. Mak, W. J. Boyle, and J. M. Penninger. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.[CrossRef][Medline]
22. Lacey, D. L., E. Timms, H. L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y. X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney, and W. J. Boyle. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:65-176.
23. Landsberger, N., and A. P. Wolffe. 1995. Role of chromatin and Xenopus laevis heat shock transcription factor in regulation of transcription from the X. laevis hsp70 promoter in vivo. Mol. Cell. Biol. 15:6013-6024.[Abstract]
24. Li, Q., M. Herrler, N. Landsberger, N. Kaludov, V. V. Ogryzko, Y. Nakatani, and A. P. Wolffe. 1998. Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo. EMBO J. 17:6300-6315.[CrossRef][Medline]
25. Maity, S. N., and B. de Crombrugghe. 1998. Role of the CCAAT-binding protein CBF/NF-Y in transcription. Trends Biochem. Sci. 23:174-178.[CrossRef][Medline]
26. Mantovani, R. 1998. A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res. 26:1135-1143.
27. Nagai, M., and N. Sato. 1999. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. Biochem. Biophys. Res. Commun. 257:719-723.[CrossRef][Medline]
28. Ohyama, Y., M. Noshiro, G. Eggertsen, O. Gotoh, Y. Kato, I. Bjorkhem, and K. Okuda. 1993. Structural characterization of the gene encoding rat 25-hydroxyvitamin D3 24-hydroxylase. Biochemistry 32:76-82.[CrossRef][Medline]
29. Prowse, D. M., L. Bolgan, A. Molnar, and G. P. Dotto. 1997. Involvement of the Sp3 transcription factor in induction of p21Cip1/WAF1 in keratinocyte differentiation. J. Biol. Chem. 272:1308-1314.
30. Rachez, C., and L. P. Freedman. 2000. Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene 246:9-21.[CrossRef][Medline]
31. Rachez, C., B. D. Lemon, Z. Suldan, V. Bromleigh, M. Gamble, A. M. Naar, H. Erdjument-Bromage, P. Tempst, and L. P. Freedman. 1999. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398:824-828.[CrossRef][Medline]
32. Rachez, C., Z. Suldan, J. Ward, C. P. Chang, D. Burakov, H. Erdjument-Bromage, P. Tempst, and L. P. Freedman. 1998. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev. 12:1787-1800.
33. Salsi, V., G. Caretti, M. Wasner, W. Reinhard, U. Haugwitz, K. Engeland, and R. Mantovani. 2003. Interactions between p300 and multiple NF-Y trimers govern cyclin B2 promoter function. J. Biol. Chem. 278:6642-6650.
34. Shang, Y., X. Hu, J. DiRenzo, M. A. Lazar, and M. Brown. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.[CrossRef][Medline]
35. Tsukii, K., N. Shima, S. Mochizuki, K. Yamaguchi, M. Kinosaki, K. Yano, O. Shibata, N. Udagawa, H. Yasuda, T. Suda, and K. Higashio. 1998. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. Biochem. Biophys. Res. Commun. 246:337-341.[CrossRef][Medline]
36. Villard, J., M. Peretti, K. Masternak, E. Barras, G. Caretti, R. Mantovani, and W. Reith. 2000. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y. Mol. Cell. Biol. 20:3364-3376.
37. Wang, D., S. Yamamoto, N. Hijiya, E. N. Benveniste, and C. L. Gladson. 2000. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions. Oncogene 23:5801-5809.
38. Wang, W., L. Dong, B. Saville, and S. Safe. 1999. Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol. Endocrinol. 13:1373-1387.
39. Wong, B. R., J. Rho, J. Arron, E. Robinson, J. Orlinick, M. Chao, S. Kalachikov, E. Cayani, F. S. Bartlett III, W. N. Frankel, S. Y. Lee, and Y. Choi. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272:25190-25194.
40. Xiong, S., S. S. Chirala, and S. J. Wakil. 2000. Sterol regulation of human fatty acid synthase promoter I requires nuclear factor-Y- and Sp-1-binding sites. Proc. Natl. Acad. Sci. USA 97:3948-3953.
41. Yamaguchi, Y., T. Narita, N. Inukai, T. Wada, and H. Handa. 2001. SPT genes: key players in the regulation of transcription, chromatin structure and other cellular processes. J. Biochem. (Tokyo) 129:185-191.
42. Yanagisawa, J., H. Kitagawa, M. Yanagida, O. Wada, S. Ogawa, M. Nakagomi, H. Oishi, Y. Yamamoto, H. Nagasawa, S. B. McMahon, M. D. Cole, L. Tora, N. Takahashi, and S. Kato. 2002. Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Mol. Cell 9:553-562.[CrossRef][Medline]
43. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi, and T. Suda. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95:3597-3602.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|